Literature DB >> 16447124

Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics.

Dennis L Stevens, Randi J Wallace, Stephanie M Hamilton, Amy E Bryant.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16447124     DOI: 10.1086/500265

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  18 in total

1.  Is linezolid superior to vancomycin for complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus?

Authors:  Andre C Kalil; Susan Puumala; Julie Stoner
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

2.  Understanding toxic shock syndrome.

Authors:  Jason P Burnham; Marin H Kollef
Journal:  Intensive Care Med       Date:  2015-05-14       Impact factor: 17.440

Review 3.  Treatment of severe skin and soft tissue infections: a review.

Authors:  Jason P Burnham; Marin H Kollef
Journal:  Curr Opin Infect Dis       Date:  2018-04       Impact factor: 4.915

4.  Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin-sensitive and methicillin-resistant Staphylococcus aureus.

Authors:  Eva J Katahira; Stephen M Davidson; Dennis L Stevens; Devin D Bolz
Journal:  J Med Microbiol       Date:  2018-12-17       Impact factor: 2.472

5.  Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndrome.

Authors:  Ashenafi Y Tilahun; Eric V Marietta; Tsung-Teh Wu; Robin Patel; Chella S David; Govindarajan Rajagopalan
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

6.  Subinhibitory Dalbavancin Attenuates Exotoxin Production from Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus In Vitro.

Authors:  Sarah E Hobdey; Eva J Katahira; Pamela Dockstader; Stephen M Davidson; Laura Bond; Devin D Bolz; Amy E Bryant; Dennis L Stevens
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

7.  New insights into the prevention of staphylococcal infections and toxic shock syndrome.

Authors:  Ying-Chi Lin; Marnie L Peterson
Journal:  Expert Rev Clin Pharmacol       Date:  2010-11-01       Impact factor: 5.045

Review 8.  The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus.

Authors:  Elisabeth Hodille; Warren Rose; Binh An Diep; Sylvain Goutelle; Gerard Lina; Oana Dumitrescu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

Review 9.  Diagnosis and management of skin and soft tissue infections in the intensive care unit: a review.

Authors:  Jason P Burnham; John P Kirby; Marin H Kollef
Journal:  Intensive Care Med       Date:  2016-10-03       Impact factor: 17.440

10.  Glycerol monolaurate and dodecylglycerol effects on Staphylococcus aureus and toxic shock syndrome toxin-1 in vitro and in vivo.

Authors:  Ying-Chi Lin; Patrick M Schlievert; Michele J Anderson; Christina L Fair; Matthew M Schaefers; Ramaiah Muthyala; Marnie L Peterson
Journal:  PLoS One       Date:  2009-10-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.